Juan Figueroa-Casas is a Respiratory physician affiliated with Texas Tech University. OpenAlex indexes 23 publications with 366 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2401 S 31st St
Temple, TX 765082707
Telephone
254-724-2111Provider last certified this registry record 12 Aug 2024.
Clinical trials
1 registered study on ClinicalTrials.gov matched to this name. Itemized trial rows, roles and sponsors are part of the full profile. Why? →
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Heron Therapeutics, Inc.Program year20241 payment
- GlaxoSmithKline, LLC.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
65%beta2-Adrenergic Agonist32.7%Albuterol Sulfate Hfa79%Ventolin Hfa21%Part D<11 patientsCorticosteroid24%Trelegy Ellipta44%Fluticasone Propionate35%Symbicort21%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
16.6%Corticosteroid16.6%Prednisone100%Part D≥28 patientsCancer & immunology
12.9%Kinase inhibitor12.9%Ofev100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Effect of Using the Rapid Shallow Breathing Index as Readiness Criterion for Spontaneous Breathing Trials in a Weaning Protocol
The American Journal of the Medical Sciences
2019 - Effect of Tidal Volume Size and Its Delivery Mode on Patient–Ventilator Dyssynchrony
Annals of the American Thoracic Society
2016 - Severe Acute Pulmonary Toxicity Associated with Brentuximab in a Patient with Refractory Hodgkin’s Lymphoma
Case Reports in Pulmonology
2016
Similar KOLs
Other experts from the same institution or the same specialty.
Debabrata Mukherjee, MD
Texas Tech University
Kenneth Nugent, MD
Texas Tech University
Javier Corral, MD
Texas Tech University
Marc Zuckerman, MD
Texas Tech University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”